Janney Montgomery Scott
AVXL icon

Janney Montgomery Scott’s Anavex Life Sciences AVXL Stock Holding History

Janney Montgomery Scott’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,164
Closed -$144K – 2918
2025
Q3 		$144K Buy
+16,164
New +$164K ﹤0.01% 2777
2023
Q3 		– Sell
-25,681
Closed -$209K – 2565
2023
Q2 		$209K Buy
+25,681
New +$220K ﹤0.01% 2439
2023
Q1 		– Sell
-24,060
Closed -$223K – 2521
2022
Q4 		$223K Buy
24,060
+13,599
+130% +$145K ﹤0.01% 2304
2022
Q3 		$108K Buy
+10,461
New +$110K ﹤0.01% 2400

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Janney Montgomery Scott's AVXL Position: Q4 2025 in Review

Janney Montgomery Scott sold out of Anavex Life Sciences (AVXL) in Q4 2025, closing a stake of 16,164 shares — an estimated $144K sold.

Janney Montgomery Scott first reported a position in AVXL in Q3 2022 and held it in 4 quarters. The position peaked at $223K in Q4 2022. 184 funds tracked by Wall St. Rank hold AVXL as of Q4 2025.

  • Janney Montgomery Scott reported no remaining Anavex Life Sciences position as of Q4 2025 after selling out during the quarter.
  • Janney Montgomery Scott sold 16,164 Anavex Life Sciences shares in Q4 2025, an estimated $144K.
  • Janney Montgomery Scott first reported a position in Anavex Life Sciences in Q3 2022 and held it in 4 quarters.
  • Janney Montgomery Scott's Anavex Life Sciences position peaked at $223K in Q4 2022.
  • 184 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2025.

Based on Janney Montgomery Scott's 13F filing for Q4 2025, filed 11 Feb 2026.